At the same time, a systematic analysis of large cohorts of patients will be fundamental to evaluate how frequently HIPK2 is deregulated and/or mutated in neurological diseases, and subsequently propose it as a diagnostic or prognostic marker in clinical practice. The gene discussed is HIPK2; the disease is nervous system disorder.